Finoriq research workspace
Autolus Therapeutics plc (AUTL) Historical Metrics
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for. Review AUTL valuation ratios, fundamentals, and filing metrics on Finoriq.
Company Snapshot
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company offers AUCATZYL, a gene therapy product consisting of autologous T cells that are transduced with a lentiviral vector to express a novel anti-CD19 chimeric antigen receptor. It also develops obe-cel, which is in phase 1 to treat systemic lupus erythematosus, progressive multiple sclerosis, B-NHL and CLL, and CNS lymphoma; obe-cel, which is in phase 2 to treat pediatric B-ALL and lupus nephritis; AUTO1/22 to treat pediatric B-ALL, which is phase 1; AUTO8, which is in phase 1 to treat multiple myeloma and light chain amyloidosis; AUTO4/5, which is in preclinical stage to treat peripheral TCL; AUTO6NG, which is in phase 1 to treat neuroblastoma; and AUTO9, which is in preclinical stage to treat acute myeloid leukemia. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.
- Company
- Autolus Therapeutics plc (AUTL)
- Ticker
- AUTL
- Market Cap
- $375.3M
- Latest Price
- $1.41
- Industry
- Biotech & Pharma
Autolus Therapeutics plc (AUTL) Current Valuation Metrics
Static valuation preview for Autolus Therapeutics plc (AUTL). Market data retrieved 2026-07-09. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| P/SMarket cap divided by latest TTM revenue. | 4.87x | Revenue | TTM Q1 2026 |
| Earnings YieldLatest TTM net income divided by market cap. | -64.1% | Net Income | TTM Q1 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -60.6% | Operating Cash Flow | TTM Q1 2026 |
| Price / BookMarket cap divided by stockholders' equity. | 4.15x | Stockholders' Equity | Q1 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.